Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia
Open Access
- 15 November 2008
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 112 (10) , 4178-4183
- https://doi.org/10.1182/blood-2008-06-165027
Abstract
The underlying pathways that lead to relapse in childhood acute lymphoblastic leukemia (ALL) are unknown. To comprehensively characterize the moleculKeywords
This publication has 30 references indexed in Scilit:
- Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group studyBlood, 2008
- BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of IkarosNature, 2008
- Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancerNature Reviews Cancer, 2008
- Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subcloneBlood, 2007
- Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemiaNature, 2007
- Glucocorticoid resistance in two key models of acute lymphoblastic leukemia occurs at the level of the glucocorticoid receptorThe FASEB Journal, 2006
- Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trialThe Lancet, 2006
- Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children's Oncology Group studyBlood, 2006
- Analysis of microsatellite instability in children treated for acute lymphocytic leukemia with elevated HPRT mutant frequenciesMutagenesis, 2004
- Allelotype analysis in relapsed childhood acute lymphoblastic leukemiaOncogene, 2003